E O’Brien

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

E O’Brien, Nely Wigler, Moshe Inbar et al. · Annals of Oncology · 2004 · 1.7K citations · Full text

Liposomal Doxorubicin Hcl, Metastatic Breast Cancer, Oncology +8

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney, Natalie McEvoy, Oisín F. McElvaney et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 665 citations · Full text

A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.

Eric J. Topol, Robert M. Califf, Michel Vandormael et al. · Circulation · 1992 · 208 citations · Full text

Dietary induced subclinical vitamin K deficiency in normal human subjects.

Guylaine Ferland, James A. Sadowski, E O’Brien · Journal of Clinical Investigation · 1993 · 146 citations · Full text

SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results

E O’Brien, Heather Anderson, E. Kaukel et al. · Annals of Oncology · 2004 · 138 citations · Full text

Medicine, Cancer Management, Immunology +8